ABSTRACT
Objective To explore the efficacy and safety of polyethylene glycol recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in preventing chemotherapy-induced neutropenia in locally advanced non small cell lung cancer (NSCLC) patients at nutritional risk. Methods A total of 337 locally advanced NSCLC patients at nutritional risk were selected. They were randomly divided into three groups: 112 cases in the non-prophylactic drug group (control group), 112 cases in the prophylactic use of rhG-CSF treatment group (rhG-CSF group), and 113 cases in the prophylactic use of PEG-rhG-CSF treatment group (PEG-rhG-CSF group). The incidence and duration of neutropenia after chemotherapy and the ratio of CD4+/CD8+T cells in peripheral blood were observed. Results The incidences of neutropenia in the control group, rhG-CSF group, and PEG-rhG-CSF group were 67.97%, 41.57%, and 38.98% (P < 0.05), respectively. The incidences of grade Ⅲ-Ⅳ neutropenia in the three groups were 22.39%, 14.25%, and 11.14% (P < 0.05); moreover, the incidence of febrile neutropenia in the three groups was 3.55%, 1.84%, and 1.21% (P < 0.05); in addition, the ratios of CD4+/CD8+T cells in peripheral blood were 1.27±0.44, 1.41±0.52, and 1.49±0.42 (P < 0.05). The duration of grade Ⅲ-Ⅳ neutropenia and the time required for the neutrophil value to reach 2.0×109/L from the lowest value in the PEG-rhG-CSF group were lower than those in the control and rhG-CSF groups (P < 0.05). Conclusion The PEG-rhG-CSF preventive treatment used in the course of chemoradiotherapy in locally advanced NSCLC patients at nutritional risk can reduce the incidence of neutropenia and improve immunologic function. PEG-rhG-CSF preventive treatment is worthy of clinical recommendation.
ABSTRACT
OBJECTIVE:To analyze the effects of mangiferin (MGF)on glucose and lipid metabolism in insulin resistance (IR)HepG2 cells,and to explore the potential mechanism. METHODS :Using human hepatoma HepG 2 cells as research objects , 1 mmol/L palmitic acid and 2 mmol/L oleic acid were used to establish the IR-HepG 2 cell model. Using metformin hydrochloride as positive control ,the effects of low-concentration ,medium-concentration and high-concentration MGF (125,250,500 μmol/L)on the corrected glucose consumption ,the contents of triglyceride (TG)and total cholesterol (TC)in IR-HepG 2 cells were detected. The mRNA expression of APN ,AdipoR2,APPL1,AMPK in the upstream of AMPK signaling pathway and IRS- 1,Akt and GLUT4 in the downstream insulin signaling pathway were detected by RT-PCR. The phosphorylation level of AMPK protein was detected by Western blot assay. RESULTS :Compared with control group ,corrected glucose consumption ,mRNA expression of APN,AdipoR2,APPL1,AMPK,IRS-1 and GLUT 4,as well as the phosphorylation level of AMPK protein were decreased significantly in model group ,while the contents of TG and TC were increased significantly (P<0.05 or P<0.01). Compared with model group , corrected glucose consumption , mRNA expression of APN (except for MGF medium-concentration and high-concentration groups ),AdipoR2,APPL1,AMPK(except for MGF medium-concentration and high-concentration groups ), IRS-1(except for MGF medium-concentration and high-concentration groups ),Akt(except for positive control group ),GLUT4 (except for MGF high-concentration group )were increased significantly in administration groups ,while the contents of TG and TC were decreased significantly (P<0.05 or P<0.01). CONCLUSIONS :Mangiferin may activate APN ,which is the upstream target of pathway ,and then regulate AMPK signaling pathway ,so as to promote glucose uptake of IR-HepG 2 cells,reduce TG and TC contents,and improve IR and abnormal glucose and lipid metabolism.
ABSTRACT
2 mg/dl);the others were in the low-risk group.High-risk patients received more superselective embolization with lower dose of embolization agent and fewer numbers of procedure(1.4 vs 2.3,P